Table 3

Number of patients with ATTR-CM identified over time

YearNewly included patients (n)Patients with prevalent ATTR-CM* (n)Population at riskPrevalence per 100 000†
200896969 256 3471.0
2009691419 340 6821.5
2010741839 415 5701.9
2011572049 482 8552.2
2012972599 555 8932.7
2013832919 644 8643.0
2014923329 747 3553.4
20151003829 851 0173.9
20161224439 995 1534.4
201711749910 120 2424.9
20188751010 230 1855.0
  • *The sum of patients included in previous years and still alive and newly included patients that year. First year of patient inclusion is 2008.

  • †Calculated as number of patients with prevalent ATTR-CM per year divided by population at risk.

  • ATTR-CM, transthyretin amyloid cardiomyopathy.